| Autor: |
Bujang MA; Clinical Research Centre, National Institutes of Health, Sarawak General Hospital, Ministry of Health Malaysia, Kuching 93586, Sarawak, Malaysia., Hon YK; Institute for Clinical Research, Ministry of Health Malaysia, Block B4, National Institutes of Health (NIH), No. 1, Jalan Setia Murni U13/52, Seksyen U13, Shah Alam 40170, Selangor, Malaysia., Lai WH; Clinical Research Centre, National Institutes of Health, Sarawak General Hospital, Ministry of Health Malaysia, Kuching 93586, Sarawak, Malaysia., Yap EPP; Clinical Research Centre, National Institutes of Health, Sarawak General Hospital, Ministry of Health Malaysia, Kuching 93586, Sarawak, Malaysia., Tiong XT; Clinical Research Centre, National Institutes of Health, Sarawak General Hospital, Ministry of Health Malaysia, Kuching 93586, Sarawak, Malaysia., Ratnasingam S; Department of Psychiatry and Mental Health, Sarawak General Hospital, Ministry of Health Malaysia, Kuching 93586, Sarawak, Malaysia., Kim ARJ; Quality Unit, Sarawak General Hospital, Ministry of Health Malaysia, Kuching 93586, Sarawak, Malaysia., Husin M; Institute for Clinical Research, Ministry of Health Malaysia, Block B4, National Institutes of Health (NIH), No. 1, Jalan Setia Murni U13/52, Seksyen U13, Shah Alam 40170, Selangor, Malaysia., Jee YYH; Radiotherapy and Oncology Unit, Sarawak General Hospital, Ministry of Health Malaysia, Kuching 93586, Sarawak, Malaysia., Ahmad NFD; Heart Center, Sarawak General Hospital, Ministry of Health Malaysia, Kuching-Samarahan Expressway, Kota Samarahan 94300, Sarawak, Malaysia., Chew CH; Institute for Medical Research, Ministry of Health Malaysia, Block C, National Institutes of Health (NIH), No. 1, Jalan Setia Murni U13/52, Seksyen U13, Shah Alam 40170, Selangor, Malaysia., Tan CHH; Division of Nephrology, Department of Medicine, Sarawak General Hospital, Ministry of Health Malaysia, Kuching 93586, Sarawak, Malaysia., Khoo SY; Clinical Research Centre, National Institutes of Health, Sarawak General Hospital, Ministry of Health Malaysia, Kuching 93586, Sarawak, Malaysia., Johari F; Clinical Research Centre, National Institutes of Health, Sarawak General Hospital, Ministry of Health Malaysia, Kuching 93586, Sarawak, Malaysia., Fong AYY; Clinical Research Centre, National Institutes of Health, Sarawak General Hospital, Ministry of Health Malaysia, Kuching 93586, Sarawak, Malaysia. |
| Abstrakt: |
Background/Objectives: This study aims to compare the health-related quality of life (HRQOL) between healthcare providers without chronic diseases and participants with chronic diseases presenting with one of the four different primary diagnoses on the health-related quality of life with six domains (HRQ-6D) scale. Methods: This is a cross-sectional study to compare the HRQOL between healthcare providers without chronic diseases and participants with chronic diseases. Data collection was performed from May 2022 to May 2023. Data for the comparison group were taken from healthcare providers without chronic diseases, and for the participant group with chronic diseases, the data were collected from actual patients with one of four types of primary diagnoses who were recruited from specialist cardiology, oncology, psychiatry, and nephrology clinics. All the participants of this study filled in the HRQ-6D. Results: There were 238 (58.6%) healthcare providers without chronic diseases who participated in this study, as well as 41 (10.1%) patients with end-stage renal disease (ESRD), 48 (11.8%) patients with cancer, and 40 (9.9%) patients who were depressed, and the remaining patients had heart disease. The means (SD) of HRQ-6D scores among healthcare providers without chronic diseases for pain, physical strength, emotion, mobility, self-care, perception of future health, and overall HRQ-6D score were 75.3% (19.8), 74.5% (21.1), 85.6% (18.4%), 93.0% (12.3), 91.6% (13.9), 74.2% (23.3), and 82.4% (13.6), respectively. In comparisons between healthcare providers without chronic diseases and participants with chronic diseases, all mean differences of the overall HRQ-6D score and its domains and dimensions were statistically significant ( p < 0.001). Conclusions: The overall score of the HRQ-6D, as well as its domains and dimensions are sensitive in detecting the study participants with chronic diseases from among those without chronic diseases. Therefore, the HRQ-6D is a reliable and valid scale to measure HRQOL. Future studies may use this scale for interventional, observational, and cost-effectiveness studies. |
